Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Diabetic cardiomyopathy
Page 1 of 1 ( 35 items )
<<
1
>>
1
Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart
2/6/2026 8:43:33 AM |
Browse: 73 |
Download: 207
2
Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy
1/14/2026 8:09:14 AM |
Browse: 102 |
Download: 291
3
Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component?
1/14/2026 8:09:13 AM |
Browse: 72 |
Download: 212
4
Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway
12/15/2025 9:46:09 AM |
Browse: 100 |
Download: 477
5
Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy
12/15/2025 9:46:06 AM |
Browse: 106 |
Download: 251
6
Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study
10/15/2025 9:03:23 AM |
Browse: 107 |
Download: 447
7
Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography
10/15/2025 9:03:21 AM |
Browse: 127 |
Download: 307
8
Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells
9/11/2025 9:41:58 AM |
Browse: 311 |
Download: 675
9
Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy
6/13/2025 11:47:55 AM |
Browse: 181 |
Download: 570
10
Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies
2/28/2025 10:47:24 AM |
Browse: 306 |
Download: 615
11
Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure
1/21/2025 6:56:34 AM |
Browse: 188 |
Download: 565
12
Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management
11/26/2024 9:16:41 AM |
Browse: 110 |
Download: 579
13
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
11/18/2024 3:30:39 AM |
Browse: 185 |
Download: 680
14
Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy
9/26/2024 8:51:02 AM |
Browse: 198 |
Download: 879
15
Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy
9/26/2024 8:51:01 AM |
Browse: 232 |
Download: 881
16
Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
8/27/2024 3:11:19 PM |
Browse: 229 |
Download: 815
17
Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure
8/26/2024 12:59:17 PM |
Browse: 81 |
Download: 387
18
Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis
7/26/2024 6:56:09 AM |
Browse: 198 |
Download: 698
19
Diabetic cardiomyopathy: Emerging therapeutic options
7/26/2024 6:56:09 AM |
Browse: 266 |
Download: 632
20
Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy
6/11/2024 2:35:35 PM |
Browse: 168 |
Download: 752
21
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
4/12/2024 1:04:39 AM |
Browse: 172 |
Download: 1401
22
Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway
12/14/2023 9:36:12 AM |
Browse: 315 |
Download: 1583
23
Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization
12/14/2023 9:36:12 AM |
Browse: 384 |
Download: 1340
24
Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid
12/14/2023 9:36:11 AM |
Browse: 376 |
Download: 1076
25
Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology
11/14/2023 6:13:55 AM |
Browse: 387 |
Download: 1478
26
Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy
5/13/2022 10:36:57 AM |
Browse: 743 |
Download: 1820
27
Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury
4/14/2022 11:27:05 AM |
Browse: 727 |
Download: 2152
28
Role of novel biomarkers in diabetic cardiomyopathy
6/4/2021 1:47:10 PM |
Browse: 822 |
Download: 1964
29
Diabetic heart disease: A clinical update
4/9/2021 5:27:04 AM |
Browse: 781 |
Download: 1900
30
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
10/15/2019 3:36:45 AM |
Browse: 1029 |
Download: 1663
31
Trace elements in diabetic cardiomyopathy: An electrophysiological overview
9/1/2014 3:13:00 PM |
Browse: 1427 |
Download: 1427
32
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management
9/1/2014 3:02:00 PM |
Browse: 1273 |
Download: 1317
33
Cardiac autonomic neuropathy in patients with diabetes mellitus
9/1/2014 12:00:00 PM |
Browse: 1765 |
Download: 1729
34
Is diabetic cardiomyopathy a specific entity?
8/27/2014 5:24:00 PM |
Browse: 1083 |
Download: 1204
35
Mechanisms underlying the impaired contractility of diabetic cardiomyopathy
8/22/2014 2:47:00 PM |
Browse: 1210 |
Download: 1339
Page 1 of 1 ( 35 items )
<<
1
>>
Write to the Help Desk
All content on this site:
Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.